- 专利标题： TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE OR NON-ALCOHOLIC STEATOHEPATITIS WITH DELAYED-RELEASE 6-MERCAPTOPURINE
-
申请号： US15294075申请日： 2016-10-14
-
公开(公告)号： US20170105996A1公开(公告)日： 2017-04-20
- 发明人: Yaron ILAN , Doina Cosma ROMAN , Michael HAYDEN , Einat AMIT-ROMACH
- 申请人： Yaron ILAN , Doina Cosma ROMAN , Michael HAYDEN , Einat AMIT-ROMACH
- 申请人地址： IL Petach-Tikva IL Jerusalem
- 专利权人： Teva Pharmaceutical Industries, Ltd.,Hadasit Medical Research Services and Development Ltd.
- 当前专利权人： Teva Pharmaceutical Industries, Ltd.,Hadasit Medical Research Services and Development Ltd.
- 当前专利权人地址： IL Petach-Tikva IL Jerusalem
- 主分类号： A61K31/52
- IPC分类号： A61K31/52 ; A61K9/00 ; A61K9/20 ; A61K45/06
摘要：
Methods of treating patients suffering from non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), including those also suffering front type II diabetes mellitus (T2DM), with a delayed release pharmaceutical composition comprising 6-mercaptopurine are disclosed.
信息查询
IPC分类:
